Cargando…
Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa
OBJECTIVES: Cryptococcal meningitis (CM)-related mortality may be prevented by screening patients for sub-clinical cryptococcal antigenaemia (CRAG) at antiretroviral-therapy (ART) initiation and pre-emptively treating those testing positive. Prior to programmatic implementation in South Africa we pe...
Autores principales: | Jarvis, Joseph N., Harrison, Thomas S., Lawn, Stephen D., Meintjes, Graeme, Wood, Robin, Cleary, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716603/ https://www.ncbi.nlm.nih.gov/pubmed/23894442 http://dx.doi.org/10.1371/journal.pone.0069288 |
Ejemplares similares
-
Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study
por: Longley, Nicky, et al.
Publicado: (2016) -
Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana
por: Tenforde, Mark W., et al.
Publicado: (2020) -
Genotypic Diversity Is Associated with Clinical Outcome and Phenotype in Cryptococcal Meningitis across Southern Africa
por: Beale, Mathew A., et al.
Publicado: (2015) -
Nosocomial Drug-Resistant Bacteremia in 2 Cohorts with Cryptococcal Meningitis, Africa
por: Rajasingham, Radha, et al.
Publicado: (2014) -
Paradoxical respiratory failure due to cryptococcal pneumonia after amphotericin B treatment for HIV-associated cryptococcal meningitis
por: Scriven, James E., et al.
Publicado: (2018)